{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T22:52:35Z","timestamp":1789253555484,"version":"build-2803163510"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["ZZ15-WT-05, CI2022C004"],"award-info":[{"award-number":["ZZ15-WT-05, CI2022C004"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The prevalence of long COVID among cancer patients remains unknown. This study aimed to determine the prevalence of long COVID and explore potential risk factors among cancer patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A systematic search was performed on PubMed, Web of Science, and Embase from database inception until 21 March 2024, to identify studies that reported long COVID in cancer patients. Two investigators independently screened the studies and extracted all information about long COVID in cancer patients for subsequent analysis. Methodological quality was assessed using the \u201cJoannagen Briggs Institute (JBI) Critical Appraisal Checklist for Studies Reporting Prevalence Data\u201d.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 13 studies involving 6,653 patients were included. The pooled prevalence of long COVID was 23.52% [95% confidence interval (CI), 12.14% to 40.64%] among cancer patients reported experiencing long COVID after acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The pooled prevalence of any long COVID in cancer patients was 20.51% (95% CI, 15.91% to 26.03%), 15.79% (95% CI, 11.39% to 21.47%), and 12.54% (95% CI, 6.38% to 23.18%) in 3, 6, and 12 months follow-up duration. Fatigue was the most common symptom, followed by respiratory symptoms, myalgia, and sleep disturbance. Patients with comorbidities had a significantly higher risk of experiencing long COVID [odds ratio (OR) = 1.72; 95% CI, 1.09 to 2.70; <jats:italic>p<\/jats:italic> = 0.019]. No statistically significant differences in sex, primary tumor, or tumor stage were detected.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Nearly a quarter of cancer patients will experience long COVID after surviving from SARS-CoV-2 infection, and this would even last for 1 year or longer. Fatigue, respiratory symptoms, myalgia, and sleep disturbance need to be more addressed and managed to reduce symptom burden on cancer patients and improve quality of life. Patients with comorbidities are at a high risk of developing long COVID. Further randomized controlled trials with rigorous methodological designs and large sample sizes are needed for future validation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:uri>, identifier CRD42023456665.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2024.1506366","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:12:06Z","timestamp":1736917926000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence and risk factors for long COVID among cancer patients: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Hongkun","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghao","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"key":"B1","unstructured":""},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2020.106197","article-title":"Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae","volume":"174","author":"Daher","year":"2020","journal-title":"Resp Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243882","article-title":"Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection","volume":"15","author":"Jacobs","year":"2020","journal-title":"PloS One"},{"key":"B4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/biomedicines9080900","article-title":"Long-term impact of COVID-19: A systematic review of the literature and meta-analysis","volume":"9","author":"Sanchez-Ramirez","year":"2021","journal-title":"Biomedicines"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00810-3","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"401","author":"Huang","year":"2023","journal-title":"Lancet (London England)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.750378","article-title":"More than 100 persistent symptoms of SARS-coV-2 (Long COVID): A scoping review","volume":"8","author":"Hayes","year":"2021","journal-title":"Front Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","author":"Xie","year":"2022","journal-title":"Nat Med"},{"key":"B8","unstructured":"COVID-19 rapid guideline: managing the long-term effects of COVID-19\n          \n          2024"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"Soriano","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"B10","unstructured":"Long COVID or post-COVID conditions\n          \n          2022"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.5856","article-title":"Definition of post-COVID-19 condition among published research studies","volume":"6","author":"Chaichana","year":"2023","journal-title":"JAMA network Open"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31173-9","article-title":"COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study","volume":"395","author":"Lee","year":"2020","journal-title":"Lancet (London England)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30314-4","article-title":"COVID-19 in patients with thoracic Malignancies (TERAVOLT): first results of an international, registry-based, cohort study","volume":"21","author":"Garassino","year":"2020","journal-title":"Lancet Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30442-3","article-title":"COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study","volume":"21","author":"Lee","year":"2020","journal-title":"Lancet Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study","volume":"395","author":"Kuderer","year":"2020","journal-title":"Lancet (London England)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2023.0010","article-title":"One-year adverse outcomes among US adults with post-COVID-19 condition vs those without COVID-19 in a large commercial insurance database","volume":"4","author":"Devries","year":"2023","journal-title":"JAMA Health Forum"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00573-8","article-title":"Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study","volume":"22","author":"Pinato","year":"2021","journal-title":"Lancet Oncol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1470-2045(20)30619-7","article-title":"The effect of clinical decision making for initiation of systemic anticancer treatments in response to the COVID-19 pandemic in England: a retrospective analysis","volume":"22","author":"Clark","year":"2021","journal-title":"Lancet Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Res ed.)"},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.1097\/XEB.0000000000000054","article-title":"Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data","volume-title":"Int J Evid Based Healthc","author":"Munn","year":"2015"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-8-79","article-title":"Undue reliance on I(2) in assessing heterogeneity may mislead","volume":"8","author":"R\u00fccker","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Software"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000001005","article-title":"Long COVID in cancer: A matched cohort study of 1-year mortality and long COVID prevalence among patients with cancer who survived an initial severe SARS-coV-2 infection","volume":"46","author":"Fankuchen","year":"2023","journal-title":"Am J Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.81182","article-title":"Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period","volume":"12","author":"Dagher","year":"2023","journal-title":"Elife"},{"key":"B26","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1186\/s12879-023-08600-6","article-title":"Characterization and predictive risk scoring of long COVID in a south Indian cohort after breakthrough COVID infection; a prospective single centre study","volume":"23","author":"Nair","year":"2023","journal-title":"BMC Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.901426","article-title":"16 months follow up of patients' Behavior and mild COVID-19 patterns in a large cohort of cancer patients during the pandemic","volume":"12","author":"Hajjaji","year":"2022","journal-title":"Front Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-0088","article-title":"Long-term effects of COVID-19 on cancer patients: the experience from Guy's Cancer Centre","volume":"18","author":"Monroy-Iglesias","year":"2022","journal-title":"Future Oncol (London England)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/iub.2536","article-title":"One-year mortality and consequences of COVID-19 in cancer patients: A cohort study","volume":"73","author":"Chai","year":"2021","journal-title":"IUBMB Life"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3390\/cancers15041269","article-title":"Long-COVID in patients with cancer previously treated with early anti-SARS-coV-2 therapies in an out-of-hospital setting: A single-center experience","volume":"15","author":"Lasagna","year":"2023","journal-title":"Cancers"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.03.019","article-title":"Persistence of long-term COVID-19 sequelae in patients with cancer: An analysis from the OnCovid registry","volume":"170","author":"Cortellini","year":"2022","journal-title":"Eur J Cancer (Oxford England: 1990)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18700","article-title":"Mortality and burden of post-COVID-19 syndrome have reduced with time across SARS-CoV-2 variants in haematology patients","volume":"201","author":"Willan","year":"2023","journal-title":"Brit J Haematol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/nu14142925","article-title":"Assessment of SARS-coV-2 infection according to previous metabolic status and its association with mortality and post-acute COVID-19","volume":"14","author":"de Arriba Fern\u00e1ndez","year":"2022","journal-title":"Nutrients"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e2240985","DOI":"10.1001\/jamanetworkopen.2022.40985","article-title":"Long-lasting symptoms after an acute COVID-19 infection and factors associated with their resolution","volume":"5","author":"Robineau","year":"2022","journal-title":"JAMA network Open"},{"key":"B35","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1182\/blood-2021-152539","article-title":"Acute and post-acute COVID-19 severity and mortality in patients with hematologic Malignancies: A population-based registry study","volume":"138","author":"Martinez-Lopez","year":"2021","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.11.011","article-title":"One-year temporal changes in long COVID prevalence and characteristics: A systematic review and meta-analysis","volume":"26","author":"Huang","year":"2023","journal-title":"Value health: J Int Soc Pharmacoeconomics Outcomes Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/pathogens11020269","article-title":"Long-term sequelae of COVID-19: A systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms","volume":"11","author":"Han","year":"2022","journal-title":"Pathog (Basel Switzerland)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00126-6","article-title":"Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study","volume":"10","author":"Huang","year":"2022","journal-title":"Lancet Respir Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2021.05.025","article-title":"Physical phenotype of blood cells is altered in COVID-19","volume":"120","author":"Kub\u00e1nkov\u00e1","year":"2021","journal-title":"Biophys J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325989","article-title":"Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2023.2220578","article-title":"A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China","volume":"12","author":"Cai","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.08.029","article-title":"Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19","volume":"81","author":"Garrigues","year":"2020","journal-title":"J infection."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2023.0750","article-title":"Risk factors associated with post-COVID-19 condition: A systematic review and meta-analysis","volume":"183","author":"Tsampasian","year":"2023","journal-title":"JAMA Intern Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00159-X","article-title":"Long COVID: systemic inflammation and obesity as therapeutic targets","volume":"10","author":"Florencio","year":"2022","journal-title":"Lancet Respir Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41387-021-00163-2","article-title":"Diabetes and COVID19: a bidirectional relationship","volume":"11","author":"Unnikrishnan","year":"2021","journal-title":"Nutr Diabetes"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102235","article-title":"Post COVID-19 syndrome (\"Long COVID\") and diabetes: challenges in diagnosis and management","volume":"15","author":"Raveendran","year":"2021","journal-title":"Diabetes Metab syndrome"},{"key":"B47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.18332\/tid\/150295","article-title":"Smoking increases the risk of post-acute COVID-19 syndrome: Results from a French community-based survey","volume":"20","author":"Barth\u00e9l\u00e9my","year":"2022","journal-title":"Tob Induc Dis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26389","article-title":"The effect of smoking on COVID-19 severity: A systematic review and meta-analysis","volume":"93","author":"Reddy","year":"2021","journal-title":"J Med Virol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2002378","DOI":"10.1183\/13993003.02378-2020","article-title":"Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects","volume":"56","author":"Jacobs","year":"2020","journal-title":"Eur Respir J"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00455.2020","article-title":"Angiotensin-converting enzyme 2 expression in COPD and IPF fibroblasts: the forgotten cell in COVID-19","volume":"320","author":"Aloufi","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2312-y","article-title":"The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice","volume":"583","author":"Bao","year":"2020","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-006434","article-title":"The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis","volume":"6","author":"Romero Starke","year":"2021","journal-title":"BMJ Global Health"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2022.2081454","article-title":"Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review","volume":"38","author":"Sylvester","year":"2022","journal-title":"Curr Med Res Opin"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01909-w","article-title":"Symptoms and risk factors for long COVID in non-hospitalized adults","volume":"28","author":"Subramanian","year":"2022","journal-title":"Nat Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1506366\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:12:14Z","timestamp":1736917934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1506366\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":54,"alternative-id":["10.3389\/fonc.2024.1506366"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1506366","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"article-number":"1506366"}}